Blue lines connecting small dots, forming a brain-like shape.

Artificial Intelligence (AI)

  • Advising life science and medical device companies looking to deploy AI-enabled products in Canada (i.e. Software as a Medical Device)
  • Advising a leading online retailer on the use of AI across its various business platforms
  • Advising a leading agricultural manufacturer regarding the testing of autonomous agricultural equipment and the use of AI
  • Acting for a leading hospitality group on the use and deployment of AI
  • Assisted Desjardins Capital and BDC Capital in their convertible private placement investment into LeddarTech Inc. in connection with the business combination with Prospector Capital.
  • Assisted McKinsey & Company on their venture capital investment and collaboration agreement as part of the $200 million Series B equity financing round of Element AI, a company that builds AI tools for enterprises.
  • Assisted McKinsey & Company in its role as a shareholder in the US$230 million sale of Element AI Inc. to Silicon Valley software company ServiceNow Inc.
  • Advised Craft Ventures in its role as lead investor in competitive intelligence platform Klue's US$15 million series A round.
  • Advised Cannacord Genuity Corp. in its role as agent in Goldspot Discoveries Inc.'s private placement of $7.5 million of subscription receipts related to the reverse takeover of Duckworth Capital Corp. Goldspot is a technology investment company that has developed artificial intelligence for mineral exploration.
  • Assisted Inpixon Canada Inc., a provider of indoor positioning analytics, in its acquisition of Locality Systems Inc., a private technology company specializing in location intelligence solutions.
  • Advised on the creation and launch of the Emerge ARK ETFs across Canada. This group of ETFs is sub-advised by a U.S.-based advisor that invests in disruptive technology, artificial intelligence and genomics.
  • Assisted Mila with privacy considerations regarding the development and deployment of a COVID-19 tracing app in Canada.
  • Advising life science and medical device companies looking to deploy AI-enabled products in Canada (i.e. Software as a Medical Device)
  • Advising a leading online retailer on the use of AI across its various business platforms
  • Advising a leading agricultural manufacturer regarding the testing of autonomous agricultural equipment and the use of AI
  • Acting for a leading hospitality group on the use and deployment of AI
  • Assisted Desjardins Capital and BDC Capital in their convertible private placement investment into LeddarTech Inc. in connection with the business combination with Prospector Capital.
  • Assisted McKinsey & Company on their venture capital investment and collaboration agreement as part of the $200 million Series B equity financing round of Element AI, a company that builds AI tools for enterprises.
  • Assisted McKinsey & Company in its role as a shareholder in the US$230 million sale of Element AI Inc. to Silicon Valley software company ServiceNow Inc.
  • Advised Craft Ventures in its role as lead investor in competitive intelligence platform Klue's US$15 million series A round.
  • Advised Cannacord Genuity Corp. in its role as agent in Goldspot Discoveries Inc.'s private placement of $7.5 million of subscription receipts related to the reverse takeover of Duckworth Capital Corp. Goldspot is a technology investment company that has developed artificial intelligence for mineral exploration.
  • Assisted Inpixon Canada Inc., a provider of indoor positioning analytics, in its acquisition of Locality Systems Inc., a private technology company specializing in location intelligence solutions.
  • Advised on the creation and launch of the Emerge ARK ETFs across Canada. This group of ETFs is sub-advised by a U.S.-based advisor that invests in disruptive technology, artificial intelligence and genomics.
  • Assisted Mila with privacy considerations regarding the development and deployment of a COVID-19 tracing app in Canada.

Key Contacts

Stay Up to Date

Subscribe to receive our insights and perspectives on the latest legal developments that will affect you.
Register